Pune, India, Nov. 21, 2022 (GLOBE NEWSWIRE) -- The global lipid nanoparticles market size was valued at USD 687.5 million in 2021. The market is anticipated to expand from USD 777.4 million in 2022 to USD 1,895.1 million in 2029, exhibiting a CAGR of 13.6% from 2022 to 2029. The expansion can be attributed to the increasing focus of pharmaceutical and biotechnology companies on drug production.
Key Industry Development:
March 2022 – Evonik Industries AG increased PhytoChol production capacity. The move was aimed at meeting the surging lipid demand for gene therapies, mRNA vaccines, and other applications.
Get a Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/lipid-nanoparticles-market-106960
Report Scope:
| Report Coverage | Details |
| Forecast Period | 2022 to 2029 |
| Forecast Period 2022 to 2029 CAGR | 13.6% |
| 2029 Value Projection | USD 1,895.1 million |
| Base Year | 2021 |
| Market Size in 2021 | USD 687.5 million |
| Historical Data for | 2018 to 2020 |
| No. of Pages | 98 |
Report Coverage:
The report gives an in-depth analysis of the significant trends that are set to propel the business landscape through the study period. It further provides an account of the critical steps taken by major industry participants for strengthening their market position. These insights have been provided after extensive research and data collation from credible resources.
Drivers and Restraints:
Industry Value to Surge Owing to Increasing Focus on Personalized Medicine
The lipid nanoparticles market growth is being fueled by the growing demand for personalized medicines for site-specific drug delivery. The nanoparticles are utilized as a carrier in the delivery of oncology and neurology-related drugs.
However, the market expansion is poised to be hindered by the enforcement of strict regulations related to investments in R&D activities.
Click here to get the short-term and long-term impact of COVID-19 on this market.
Please visit: https://www.fortunebusinessinsights.com/lipid-nanoparticles-market-106960
Segments:
Solid Lipid Nanoparticles Segment to Record Commendable Expansion Owing to Associated Benefits
On the basis of type, the market is subdivided into solid lipid nanoparticles, nanostructured lipid carriers, and others. Of these, the solid lipid nanoparticles segment is anticipated to depict a notable rise over the analysis period. The rise is being driven by the benefit of high loading capacity and bioavailability.
Therapeutics Segment to Record Substantial Growth Owing to Escalating Product Usage as Carriers
Based on application, the market is segregated into research and therapeutics. The therapeutics segment is slated to grow at a remarkable CAGR throughout the forecast period. The escalation can be attributed to the surging product usage in manufacturing drugs for the treatment of numerous diseases, including cancer.
Pharmaceutical & Biotechnology Companies to Record Lucrative Growth Impelled by Increasing Product Deployment for Drug Development
Based on end-user, the market is fragmented into pharmaceutical & biotechnology companies, academic & research, and others. Of these, the pharmaceutical & biotechnology companies segment is projected to record substantial expansion growth through the study period. The rise can be attributed to the increasing product usage in the manufacturing and marketing of various drugs.
Based on region, the market is categorized into Europe, Asia Pacific, North America, and the rest of the world.
Lipid Nanoparticles Market Segments:
| Market Segmentation | By Type
|
By Application
| |
By End User
| |
By Geography
|
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/lipid-nanoparticles-market-106960
Regional Insights:
North America to Lead Driven by Presence of Major Players
The North America lipid nanoparticles market share is estimated to register substantial growth through the analysis period. The rise can be attributed to the presence of key industry players and escalating focus on geographical expansion.
The Europe market is poised to record lucrative expansion over the forecast period. The surge is being driven by growing investments in R&D activities.
Competitive Landscape:
Market Participants Enter into Collaborations to Expand Product Reach
Major industry players are entering into partnership agreements and collaborations for increasing product reach and enabling geographical expansion. Numerous companies are participating in research activities and trade conferences. Some of the additional initiatives comprise mergers, acquisitions, and the formation of alliances.
List of Key Players Mentioned in the Report:
- Merck KGaA (Germany)
- Evonik Industries AG (Germany)
- Gattefossé (France)
- Precision NanoSystems (Canada)
- IOI Oleo GmbH (Germany)
Quick Buy Lipid Nanoparticles Market Research Report – https://www.fortunebusinessinsights.com/checkout-page/106960
Table of Content
- Introduction
- Research Scope
- Market Segmentation
- Research Methodology
- Definitions and Assumptions
- Executive Summary
- Market Dynamics
- Market Drivers
- Market Restraints
- Market Opportunities
- Market Trends
- Key Insights
- New Product Launches, By Key Players
- Key Industry Developments- Mergers, Acquisitions & Partnerships
- Recent Advances in Drug Delivery Using Lipid Nanoparticles
- Impact of COVID-19 on the Market
- Global Lipid Nanoparticles Market Analysis, Insights and Forecast, 2018-2029
- Market Analysis, Insights and Forecast – By Type
- Solid Lipid Nanoparticles (SLNs)
- Nanostructured Lipid Carriers (NLCs)
- Others
- Market Analysis, Insights and Forecast – By Application
- Therapeutics
- Research
- Market Analysis, Insights and Forecast – By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
- Market Analysis, Insights and Forecast – By Region
- North America
- Europe
- Asia Pacific
- Rest of the World
- Market Analysis, Insights and Forecast – By Type
- North America Lipid Nanoparticles Market Analysis, Insights and Forecast, 2018-2029
- Market Analysis, Insights and Forecast – By Type
- Solid Lipid Nanoparticles (SLNs)
- Nanostructured Lipid Carriers (NLCs)
- Others
- Market Analysis, Insights and Forecast – By Application
- Therapeutics
- Research
- Market Analysis, Insights and Forecast – By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
- Market Analysis, Insights and Forecast – By Country
- U.S.
- Canada
- Market Analysis, Insights and Forecast – By Type
- Europe Lipid Nanoparticles Market Analysis, Insights and Forecast, 2018-2029
- Market Analysis, Insights and Forecast – By Type
- Solid Lipid Nanoparticles (SLNs)
- Nanostructured Lipid Carriers (NLCs)
- Others
- Market Analysis, Insights and Forecast – By Application
- Therapeutics
- Research
- Market Analysis, Insights and Forecast – By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
- Market Analysis, Insights and Forecast – By Country/ Sub-region
- U.K.
- Germany
- France
- Italy
- Spain
- Scandinavia
- Rest of Europe
- Market Analysis, Insights and Forecast – By Type
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
